| 1 |
30729097 | Survivin in Insulin-Like Growth Factor-Induced Resistance to Lapatinib in Head and Neck Squamous Carcinoma Cells. | 2019 |
4 |
| 2 |
26621843 | The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells. | 2016 Jan 19 |
3 |
| 3 |
25865888 | Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains. | 2015 Apr 21 |
1 |
| 4 |
25886138 | Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors. | 2015 Apr 4 |
2 |
| 5 |
26484410 | Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma. | 2015 Nov 3 |
1 |
| 6 |
24655723 | miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer. | 2014 Mar 24 |
1 |
| 7 |
24973425 | Functional genetic approach identifies MET, HER3, IGF1R, INSR pathways as determinants of lapatinib unresponsiveness in HER2-positive gastric cancer. | 2014 Sep 1 |
2 |
| 8 |
21447712 | Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma. | 2011 Apr |
1 |
| 9 |
17308062 | Lapatinib induces apoptosis in trastuzumab-resistant breast cancer cells: effects on insulin-like growth factor I signaling. | 2007 Feb |
1 |